111,302 Shares in Integer Holdings Corporation $ITGR Bought by Nantahala Capital Management LLC

Nantahala Capital Management LLC purchased a new stake in Integer Holdings Corporation (NYSE:ITGR) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 111,302 shares of the medical equipment provider’s stock, valued at approximately $10,401,172.

A number of other large investors have also recently bought and sold shares of ITGR. Barrow Hanley Mewhinney & Strauss LLC bought a new position in Integer in the 2nd quarter valued at about $29,000. EverSource Wealth Advisors LLC raised its position in Integer by 48.1% during the first quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 117 shares in the last quarter. Harbor Investment Advisory LLC acquired a new position in Integer during the second quarter valued at approximately $42,000. TD Private Client Wealth LLC lifted its stake in Integer by 1,037.5% during the fourth quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after purchasing an additional 415 shares during the last quarter. Finally, Parkside Financial Bank & Trust lifted its stake in Integer by 135.5% during the fourth quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after purchasing an additional 267 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Performance

NYSE ITGR opened at $125.30 on Friday. The firm’s fifty day moving average price is $107.58 and its two-hundred day moving average price is $94.48. The stock has a market cap of $4.26 billion, a PE ratio of 34.24, a PEG ratio of 2.96 and a beta of 0.61. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.41 and a current ratio of 3.73. Integer Holdings Corporation has a fifty-two week low of $62.00 and a fifty-two week high of $126.14.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.38 by $0.22. Integer had a return on equity of 12.79% and a net margin of 6.97%.The company had revenue of $464.11 million during the quarter, compared to analysts’ expectations of $451.07 million. During the same period in the prior year, the company earned $1.55 EPS. Integer’s revenue was down 2.6% compared to the same quarter last year. On average, equities analysts expect that Integer Holdings Corporation will post 6.09 EPS for the current fiscal year.

Wall Street Analyst Weigh In

ITGR has been the topic of several recent analyst reports. HC Wainwright reiterated a “buy” rating on shares of Integer in a research note on Friday, July 24th. Piper Sandler lowered Integer from an “overweight” rating to a “hold” rating and set a $127.00 price objective on the stock. in a research note on Monday, August 3rd. Benchmark cut Integer from a “buy” rating to a “hold” rating in a research report on Thursday, August 13th. Citigroup boosted their target price on Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 8th. Finally, Zacks Research raised shares of Integer from a “strong sell” rating to a “hold” rating in a report on Monday, July 20th. One equities research analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to data from MarketBeat.com, Integer has an average rating of “Hold” and an average price target of $109.86.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.